Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Maria Francisca Ham is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
Ekspresi CD 19 sebagai Penanda Potensial Terapi Target pada Limfoma Non Hodgkin Sel B
20/04/20 → 31/12/20
Project: Research
-
Clinicopathological Profile of Thyroid Carcinoma in Young Patients: An Indonesian Single-Center Study
Harahap, A. S., Sari, D. G., Stephanie, M., Siswoyo, A. D., Zaid, L. S. M., Kartini, D., Ham, M. F. & Tarigan, T. J. E., 11 Jan 2022, In: Journal of Thyroid Research. 2022, 9944083.Research output: Contribution to journal › Article › peer-review
Open Access -
Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report
Yulian, E. D., Hwei, L. R. Y., Tambun, R., Siswoyo, A. D., Ham, M. F. & Suroyo, I., Apr 2022, In: International Journal of Surgery Case Reports. 93, 106954.Research output: Contribution to journal › Article › peer-review
Open Access -
Expression of programmed cell death ligand-1 protein in germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
Asrini, R., Ham, M. F., Asmarinah, A., Harahap, A. S. & Hardjolukito, E. SR., Feb 2022, In: Molecular and Clinical Oncology. 16, 2, 42.Research output: Contribution to journal › Article › peer-review
Open Access -
MUM1 Expression versus Hans Algorithm to Predict Prognosis in Indonesian Diffuse Large B-Cell Lymphoma Patients Receiving R-CHOP
Irawan, C., Iskandar, M., Harahap, A. S., Rumende, C. M. & Ham, M. F., 2022, In: Cancer Management and Research. 14, p. 925-935 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19
Rajabto, W., Chandika, V., Harahap, A. S. & Ham, M. F., 2022, In: International Medical Case Reports Journal. 15, p. 269-273 5 p.Research output: Contribution to journal › Article › peer-review
Open Access